Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland

11. Literatur 217
249. Lofgren M, Andersson I, Lindholm K. Stereotactic fin-needle aspiration for cytologic
diagnosis of nonpalpable breast lesions. AJR 1990;154:1191–5.
250. Lohr KN. The quality of practice guidelines and the quality of health care. Guidelines
in health care. Report of a WHO Conference January 1997. Baden-Baden: Nomos
Verlagsgesellschaft, 1998.
251. London SJ, Connelly JL, Schnitt SJ, et al. A prospective study of benign breast disease
and the risk of breast cancer. JAMA 1992;267:941–4.
252. Longnecker MP.Alcohol consumption in relation to risk of breast cancer: meta analysis
and review. Cancer Causes Control 1994;5:73–82.
253. Lorenz W. Outcome: Definition and methods of evaluation. In: Troidl H, McKneally
MF, Mulder DS, Wechsler AS et al (eds) Surgical research. Basic principles and clinical
practice, 3rd ed. Springer, New York 1998;513.
254. Lorenz W, Koller M. Empirically-based concepts of outcome and quality of life in
medicine. In: Gimmler A.Ch.Lenk, G.Aumüller (editors). Health and quality of life.
Philosophical, medical and cultural aspects. Münster: LIT-Verlag 2002.
255. Lorenz W, Ollenschläger G, Geraedts M, Gerlach F, Gangjour A, Helou A, et al. Das
Leitlinien Manual: Entwicklung und Implementierung von Leitlinien in der Medizin.
ZaeFQ95:1–84.
256. Lorenz W, Troidl H, Solomkin JS, Nies C. Second step: Testing – Outcome measurements.
World J Surg 1999;23:768.
257. Lundström E, et al. Mammographic breast density during hormone replacement
therapy: effects of continuous combination, unopposed transdermal and low-potency
estrogen regimens. Climacteric 2001;4:42–8.
258. Lundström E, Christow A, Kersemaekers W, Svane G, Azavedos E, Soderqvist G, et al.
Effects of tibolone and continuous combined hormone replacement therapy on
mammographic breast density. Am J Obstet Gynecol 2002;186:722.
259. Lundström E, Wilczek B, von Palffy Z, Söderqvist G, von Schoultz B. Mammographic
breast density during hormone replacement therapy: differences according to
treatment. Am J Obstet Gynecol 1999;181:348–52.
260. Madjar H. Kursbuch Mammasonographie. Georg-Thieme-Verlag Stuttgart 1999.
261. Madjar H, Ladner HA, Sauerbrei W, Oberstein A, Prömpeler HJ, Pfleiderer A.
Preoperative staging of breast cancer by palpation, mammography and high resolution
ultrasound. Ultrasound Obstet Gynecol 1993;3:185–90.
262. Madjar H, Mundinger A, Lattermann U, Gufler H, Prömpeler HJ. Phantomuntersuchungen
von Ultraschallgeräten zur Qualitätsverbesserung in der Mammadiagnostik.
Ultraschall in Med 1996;17:85–95.
263. Madjar H, Rickard M, Jellins J, Otto R. IBUS Guidelines for the Ultrasonic Examination
of the Breast. Eur J Ultrasound 1999;9:99–102.
264. Madjar H, Sauerbrei W, Prömpeler HJ,Wolfarth R, Gufler H. Color doppler and duplex
flow analysis for classification of breast lesions. Gynecol Oncol 1997;64:392–403.
265. Madjar H. Mehrstufenkonzept AK Mammasonographie DEGUM. Ultraschall in Med
2002;23:62–3.
266. Mansour E, Gray R, Shatila A, Tormey D, Cooper M, Osborne C, et al. Survival
advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten year
analysis – an intergroup study. J Clin Oncol 1998;16:3486–92.
267. Margolis CZ. Methodology matters VII. Clinical practice guidelines: methodological
considerations. Int J Qual Health Care 1997;9:303–6.
268. Marks J, Goldberg D, Hilier V. Determinants of the ability of general practitioners to
detect psychiatric illness. Psychol Med 1979;9:337–53.
269. Martin DK, McKneally MF. Qualitative research. In: Troidl H, McKneally MF, Mulder
DS, Wechsler AS, McPeek B, Spitzer WO., eds. Surgical research. Basic principles and
clinical practice. New York: Springer 1998;235–41.